Trial of XELIRI/FOLFIRI + Simvastatin Followed by Simvastatin Maintenance in Metastatic Colorectal Cancer
NCT01238094
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
258
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Simvastatin
Sponsor
Samsung Medical Center